ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

747 hedge funds and large institutions have $31.2B invested in Alexion Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 242 increasing their positions, 311 reducing their positions, and 148 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

24% less call options, than puts

Call options by funds: $202M | Put options by funds: $267M

44% less first-time investments, than exits

New positions opened: 83 | Existing positions closed: 148

Holders
747
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
70
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$202M
Puts
$267M
Net Calls
Net Calls Change

Top Buyers

1 +$612M
2 +$539M
3 +$526M
4
Barclays
Barclays
United Kingdom
+$491M
5
Citigroup
Citigroup
New York
+$330M

Top Sellers

1 -$917M
2 -$729M
3 -$421M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$314M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$313M
Name Holding Trade Value Shares
Change
Change in
Stake
226
$8.53M
227
$8.07M
228
$7.9M
229
$7.85M
230
$7.8M
231
$7.75M
232
$7.63M
233
$7.63M
234
$7.55M
235
$7.15M
236
$7.15M
237
$7.14M
238
$7.13M
239
$6.88M
240
$6.87M
241
$6.79M
242
$6.29M
243
$6.24M
244
$6.2M
245
$6.13M
246
$6.12M
247
$6.12M
248
$6.08M
249
$6.02M
250
$5.85M